Newstral
Article
Bbarrons.com on 2022-01-28 11:39
Biogen Sells Stake in Biosimilars Venture for $2.3 Billion1 min read
Related news
- Embattled Biogen sells stake in biosimilars venture for $2.3Bbizjournals.com
- Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologicsjdsupra.com
- Samsung Bioepis and Biogen Announces Pooled Analysis of Three Anti-TNF Biosimilarsjdsupra.com
- BiogenForbes
- Biopharma Closely Watching Biden’s Pick For The Next FDA Commissioner – With Biogen Having The Most At StakeForbes
- Biogen Increases Ownership Stake in Samsung Bioepisjdsupra.com
- HP sells $2.3 billion China unit stakeReuters
- BBerkshire Hathaway Cuts Stake in U.S. Bancorp By More Than 56% to $2.4 billion1 min readbarrons.com
- BBiogen: Biotech Bargainbarrons.com
- Founder of China’s Meituan Donates $2.3 Billion Stakewsj.com
- Aberdeen buys out joint venture stakeThe Herald
- FBiogen predicts preventive Alzheimer’s drugft.com
- Biogen tops Street 3Q forecastsdothaneagle.com
- Verizon Takes Stake in DreamWorks’ AwesomenessTV Venturewsj.com
- Williams sells stake in gas gathering venturejournalrecord.com
- Barnwell buys stake in Texas venturestaradvertiser.com
- Foreign Investors Stake N86.1bn on 2.3% of Dangote Cementthisdaylive.com
- HP sells stake in Chinese unit for $2.3-billionThe Globe and Mail
- Dynegy to Buy Stake in Joint Venturewsj.com